MARY JONES: Open Payments
NPI 1851378434 · FALLS CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 46 payments from 10 companies in 2025. Trend: 2023 $336 · 2024 $476 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $229 |
| ABBVIE INC. | 16 | $209 |
| Vanda Pharmaceuticals Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Neurocrine BioSciences, Inc. | 3 | $50 |
| Amgen Inc. | 2 | $27 |
| Medtronic, Inc. | 1 | $17 |
| Insmed, Inc. | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: VRAYLAR, REXULTI, ABILIFY ASIMTUFII, Wegovy, CAPLYTA, INGREZZA, UBRELVY, ABILIFY MAINTENA.
Industry payments across NE — which companies pay providers there.
